Yingru Liu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2014First federal award
$3.4MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 22, 2022 | NIH | SBIR Phase I OMV vaccine against Gonorrhea | $300K | THERAPYX, INC. |
| Jul 31, 2019 | NIH | SBIR Phase I Encapsulated anti-IL-10 for the immune therapy of gonorrhea infection | $239K | THERAPYX, INC. |
| Jan 5, 2018 | NIH | SBIR Phase II Experimental Gonococcal Vaccine | $989K | THERAPYX, INC. |
| Feb 10, 2017 | NIH | SBIR Phase II Experimental Gonococcal Vaccine | $805K | THERAPYX, INC. |
| Apr 27, 2015 | NIH | SBIR Phase II Therapy and Prophylaxis for Genital Tract Infection | $749K | THERAPYX, INC. |
| Dec 17, 2014 | NIH | SBIR Phase I Experimental Gonococcal Vaccine | $271K | THERAPYX, INC. |
Peer ranks
Federal funding#523
Awards as PI#315
Patents#273
Companies
- THERAPYX, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.